SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-118413
Filing Date
2016-08-11
Accepted
2016-08-11 17:15:28
Documents
3
Period of Report
2016-08-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v446720_8k.htm 8-K 24161
2 EXHIBIT 99.1 v446720_ex99-1.htm EX-99.1 11824
3 GRAPHIC image_001.jpg GRAPHIC 30713
  Complete submission text file 0001144204-16-118413.txt   79705
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 161825450
SIC: 2835 In Vitro & In Vivo Diagnostic Substances